Author

Ziad Younes 1

1 GastroOne,Germantown,United States of America

ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR CROHN’S DISEASE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

Stefan Schreiber, Corey A Siegel, Keith Friedenberg, Ursula Seidler, Bal R. Bhandari, Ziad Younes, KE WANG, Matthew McKevitt, Sally Zhao, Bittoo Kanwar, John Sundy, Scott D. Lee, Edward V Loftus Jr

ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

William Sandborn, Bal R. Bhandari, Charles Randall, Ziad Younes, Tomasz Romańczyk, Hao Chai, Matthew McKevitt, Sally Zhao, Bittoo Kanwar, John Sundy, Satish Keshav, Silvio Danese

Item 1 - 2 / 2
1